Cristina
Peña Maroto
Novartis (Sweden)
Täby, SueciaPublications in collaboration with researchers from Novartis (Sweden) (1)
2010
-
PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
Neuro-Oncology, Vol. 12, Núm. 9, pp. 967-975